Longevity Health Holdings, Inc.
XAGE
$0.21
-$0.01-5.83%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -21.37% | -23.24% | 2,602.86% | 1,977.56% | 3,994.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.37% | -23.24% | 2,602.86% | 1,977.56% | 3,994.31% |
| Cost of Revenue | 304.46% | 46.11% | 18,150.00% | 3,956.25% | 16,333.33% |
| Gross Profit | -56.72% | -85.06% | 1,457.67% | 1,372.61% | 3,685.83% |
| SG&A Expenses | -54.31% | -3.90% | 196.52% | 36.43% | 77.57% |
| Depreciation & Amortization | -40.09% | -37.50% | -11.41% | -9.44% | -5.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -47.56% | -4.97% | 169.24% | 33.32% | 83.63% |
| Operating Income | 55.29% | -1.22% | -126.94% | -5.25% | -43.26% |
| Income Before Tax | 0.16% | 4.93% | -102.35% | 50.33% | 42.91% |
| Income Tax Expenses | -- | -- | 137.31% | -- | -- |
| Earnings from Continuing Operations | 0.16% | 4.93% | -127.85% | 50.33% | 42.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.16% | 4.93% | -127.85% | 50.33% | 42.91% |
| EBIT | 55.29% | -1.22% | -126.94% | -5.25% | -43.26% |
| EBITDA | 55.50% | -1.84% | -129.54% | -5.44% | -44.24% |
| EPS Basic | 51.21% | 50.39% | 11.09% | 79.92% | 67.39% |
| Normalized Basic EPS | 78.07% | 47.07% | 17.45% | 78.71% | 70.52% |
| EPS Diluted | 51.21% | 50.39% | 11.09% | 79.92% | 67.39% |
| Normalized Diluted EPS | 78.07% | 47.07% | 17.45% | 78.71% | 70.52% |
| Average Basic Shares Outstanding | 104.60% | 91.68% | 156.29% | 147.33% | 75.03% |
| Average Diluted Shares Outstanding | 104.60% | 91.68% | 156.29% | 147.33% | 75.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |